Pharmaceutical Formulation Scientists are integral to the drug development process, specializing in creating drug products that are both effective and safe for patient use. They focus on transforming active pharmaceutical ingredients (APIs) into practical, stable, and reliable dosage forms, such as tablets, capsules, injectables, or topical creams. Their expertise involves understanding the physicochemical properties of both the drug and excipients to design formulations that optimize bioavailability, stability, and controlled release. This is essential to ensuring that the drug performs as intended once administered to the patient, maintaining therapeutic efficacy over its shelf life. Their work is vital to the development of new therapies, ensuring that the drug product remains consistent and effective across all stages of production and usage.
These scientists work collaboratively with teams from various disciplines, including regulatory affairs, analytical chemistry, and manufacturing, to develop formulations that meet rigorous safety and quality standards. They are responsible for conducting pre-formulation studies, stability testing, and compatibility studies to determine the best formulation strategies for a given drug. Furthermore, they also play a critical role in scaling up drug production, ensuring that formulations maintain their quality at large manufacturing volumes. As the pharmaceutical landscape evolves, pharmaceutical formulation scientists are at the forefront of developing innovative drug delivery systems, including biologics, vaccines, and personalized medicines, ultimately improving patient care and the success of new therapeutic products.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand